Genberg, Becky L.Wilson-Barthes, Marta G.Omodi, VictorHogan, Joseph W.Steingrimsson, JonWachira, JuddyPastakia, SonakTran, Dan N.Kiragu, Zana W.Ruhl, Laura J.Rosenberg, MollyKimaiyo, SylvesterGalárraga, Omar2022-02-022022-02-022021-10Genberg, B. L., Wilson-Barthes, M. G., Omodi, V., Hogan, J. W., Steingrimsson, J., Wachira, J., Pastakia, S., Tran, D. N., Kiragu, Z. W., Ruhl, L. J., Rosenberg, M., Kimaiyo, S., & Galárraga, O. (2021). Microfinance, retention in care, and mortality among patients enrolled in HIV 2 Care in East Africa. AIDS, 35(12), 1997-2005. https://doi.org/10.1097/QAD.00000000000029870269-9370https://hdl.handle.net/1805/27666Objective: To measure associations between participation in community-based microfinance groups, retention in HIV care, and death among people with HIV (PWH) in low-resource settings. Design and methods: We prospectively analyzed data from 3609 patients enrolled in an HIV care program in western Kenya. HIV patients who were eligible and chose to participate in a Group Integrated Savings for Health Empowerment (GISHE) microfinance group were matched 1 : 2 on age, sex, year of enrollment in HIV care, and location of initial HIV clinic visit to patients not participating in GISHE. Follow-up data were abstracted from medical records from January 2018 through February 2020. Logistic regression analysis examined associations between GISHE participation and two outcomes: retention in HIV care (i.e. >1 HIV care visit attended within 6 months prior to the end of follow-up) and death. Socioeconomic factors associated with HIV outcomes were included in adjusted models. Results: The study population was majority women (78.3%) with a median age of 37.4 years. Microfinance group participants were more likely to be retained in care relative to HIV patients not participating in a microfinance group [adjusted odds ratio (aOR) = 1.31, 95% confidence interval (CI) 1.01–1.71; P = 0.046]. Participation in group microfinance was associated with a reduced odds of death during the follow-up period (aOR = 0.57, 95% CI 0.28–1.09; P = 0.105). Conclusion: Participation in group-based microfinance appears to be associated with better HIV treatment outcomes. A randomized trial is needed to assess whether microfinance groups can improve clinical and socioeconomic outcomes among PWH in similar settings.enPublisher PolicyEast AfricaAIDSmortality ratesMicrofinance, retention in care, and mortality among patients enrolled in HIV 2 Care in East AfricaArticle